These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35359981)

  • 1. CASE REPORT: Serial Cases of False-Positive Flow-Cytometry T Cell Crossmatch Associated With Anti-Blood Type Antibodies in Patients Undergoing ABO-Incompatible Kidney Transplantation.
    Hayashi A; Yamamoto I; Kawabe M; Kobayashi A; Ito M; Hotta K; Shinohara N; Tasaki T; Yokoo T; Iwami D
    Front Immunol; 2022; 13():862652. PubMed ID: 35359981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful unintentional ABO-incompatible renal transplantation: Blood group A1B donor into an A2B recipient.
    Fadeyi EA; Stratta RJ; Farney AC; Pomper GJ
    Am J Clin Pathol; 2014 May; 141(5):724-6. PubMed ID: 24713746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ABO incompatibility on T-cell flow cytometry cross-match results prior to living donor kidney transplantation.
    Lindemann M; Lenz V; Nyadu B; Heinemann FM; Heinold A; Guberina H; Eisenberger U; Lachmann N; Schönemann C; Kribben A; Paul A; Horn PA; Witzke O
    Cytometry B Clin Cytom; 2018 Jul; 94(4):623-630. PubMed ID: 27860206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of rituximab on the T-cell flow cytometric crossmatch.
    Doss SA; Mittal S; Daniel D
    Transpl Immunol; 2021 Feb; 64():101360. PubMed ID: 33359130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-Cell-Positive, B-Cell-Negative Flow Cytometry Crossmatch: Frequency, HLA Locus Specificity, and Mechanisms Among 3073 Clinical Flow Cytometry Crossmatch Tests.
    Putheti P; Sharma VK; Friedlander R; Menon A; Dadhania D; Muthukumar T; Suthanthiran M
    Exp Clin Transplant; 2022 Feb; 20(2):180-189. PubMed ID: 34981713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology Status of Patients During Kidney Transplant.
    Abdrakhmanova S; Turganbekova A; Zhanzakova Z; Zhangaziyeva K
    Exp Clin Transplant; 2024 Jan; 22(Suppl 1):180-186. PubMed ID: 38385394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
    Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case report.
    Hart JD; Lutz CT; Jennings CD; May JR; Nelson K; Jacobs S; Hoopes CW
    Transplant Proc; 2015 Apr; 47(3):831-3. PubMed ID: 25891741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
    Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
    Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pronase independent flow cytometry crossmatching of rituximab treated patients.
    Alheim M; Wennberg L; Wikström AC
    Hum Immunol; 2018 Feb; 79(2):132-135. PubMed ID: 29157993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Third Kidney Transplant After Desensitization for Combined Human Leucocyte Antigen (HLA) and ABO Incompatibility: A Case Report and Review of Literature.
    Thukral S; Shinde N; Mukherjee K; Ray DS
    Am J Case Rep; 2019 Mar; 20():285-289. PubMed ID: 30828083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens.
    Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM
    Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful ABO-Incompatible Renal Transplantation:  Blood Group A1B Donor Into A2B Recipient With Anti-A1 Isoagglutinins.
    Fadeyi EA; Stratta RJ; Farney AC; Pomper GJ
    Am J Clin Pathol; 2016 Aug; 146(2):268-71. PubMed ID: 27473744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Positive Donor-Specific HLA Antibodies Crossmatch on Graft Survival in ABO-Incompatible Liver-Kidney Transplantation: A Case Report.
    Hsieh CE; Yang Y; Lin KH; Chen CC; Ko CJ; Hsu YL; Lin CC; Hung YJ; Lin PY; Wang SH; Chen YL
    Transplant Proc; 2018 Dec; 50(10):4008-4011. PubMed ID: 30522859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.
    Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N
    Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
    Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
    J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperacute rejection in ABO-incompatible kidney transplantation: Significance of isoagglutinin subclass.
    Yang JJ; Baek CH; Kim H; Kwon H; Shin S; Kim YH; Hwang SH; Oh HB; Park SK; Cho D; Ko DH
    Transpl Immunol; 2021 Dec; 69():101484. PubMed ID: 34678463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.